Apollo Commercial Real Estate Finance Other Income (Expense) decreased by 893.9% to -$17.15M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 142.3%, from $40.56M to -$17.15M. Over 3 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 46.4% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.05M | -$24.41M | -$3.88M | -$32.52M | -$84.84M | -$92.78M | $18.63M | $21.56M | -$44.17M | $56.01M | -$19.56M | -$1.36M | $60.10M | -$76.65M | $40.56M | $73.71M | -$16.94M | $2.16M | -$17.15M |
| QoQ Change | — | -702.2% | +84.1% | -738.3% | -160.9% | -9.4% | +120.1% | +15.7% | -304.9% | +226.8% | -134.9% | +93.0% | >999% | -227.5% | +152.9% | +81.7% | -123.0% | +112.8% | -893.9% |
| YoY Change | — | — | — | — | <-999% | -280.1% | +157.3% | +125.4% | +52.4% | — | -205.0% | -106.3% | +236.1% | -236.9% | +307.3% | >999% | -128.2% | +102.8% | -142.3% |